Multiple myeloma, version 2.2016 Journal Article
| Authors: | Anderson, K. C.; Alsina, M.; Atanackovic, D.; Biermann, J. S.; Chandler, J. C.; Costello, C.; Djulbegovic, B.; Fung, H. C.; Gasparetto, C.; Godby, K.; Hofmeister, C.; Holmberg, L.; Holstein, S.; Huff, C. A.; Kassim, A.; Krishnan, A. Y.; Kumar, S. K.; Liedtke, M.; Lunning, M.; Raje, N.; Singhal, S.; Smith, C.; Somlo, G.; Stockerl-Goldstein, K.; Treon, S. P.; Weber, D.; Yahalom, J.; Shead, D. A.; Kumar, R. |
| Article Title: | Multiple myeloma, version 2.2016 |
| Abstract: | Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics from the American Cancer Society indicate that the incidence of MM is increasing. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) included in this issue address management of patients with solitary plasmacytoma and newly diagnosed MM. © JNCCN-Journal of the National Comprehensive Cancer Network. |
| Keywords: | immunohistochemistry; cancer surgery; lenalidomide; prednisone; thalidomide; allogeneic stem cell transplantation; review; doxorubicin; interferon; cancer combination chemotherapy; cancer radiotherapy; nuclear magnetic resonance imaging; positron emission tomography; follow up; antineoplastic agent; cancer diagnosis; cancer incidence; protein blood level; low drug dose; bortezomib; computer assisted tomography; multiple myeloma; erythropoietin; calcium; cyclophosphamide; dexamethasone; immunoglobulin; melphalan; vincristine; calcium blood level; creatinine blood level; plasmacytoma; practice guideline; stem cell transplantation; albumin; add on therapy; bone marrow biopsy; cancer stem cell; thrombocyte count; creatine; interpersonal communication; lactate dehydrogenase; beta 2 microglobulin; physical examination; blood cell count; urinalysis; cancer classification; m protein; immunoglobulin blood level; graft recipient; myeloma; zoledronic acid; carfilzomib; non profit organization; randomized controlled trial (topic); pamidronic acid; phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); clodronic acid; albumin blood level; maintenance chemotherapy; asymptomatic disease; human; solitary plasmacytoma; active multiple myeloma; smoldering myeloma; tandem stem cell transplantation |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 13 |
| Issue: | 11 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2015-11-01 |
| Start Page: | 1398 |
| End Page: | 1435 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26553768 |
| PMCID: | PMC4891187 |
| DOI: | 10.6004/jnccn.2015.0167 |
| DOI/URL: | |
| Notes: | Export Date: 2 December 2015 -- Source: Scopus |
